动物研究揭示Beclin-1自噬通路下调是自闭症谱系障碍的共享机制:系统综述与荟萃分析
该系统综述与荟萃分析纳入192项动物研究,评估多种遗传和环境自闭症谱系障碍(ASD)模型中的mTOR信号通路。随机效应模型发现mTOR通路相关蛋白显著改变,且Beclin-1在所有亚组中一致下调,提示自噬是ASD的共同机制。
要点
- mTOR通路相关蛋白在ASD动物模型中存在显著改变。
- Beclin-1在所有亚组中一致下调,提示自噬参与ASD。
- p-AKT、PTEN等蛋白改变具有物种、性别、年龄或脑区特异性。
核心结论
- ASD动物模型存在mTOR通路失调,Beclin-1一致下调提示自噬是共同机制。
研究设计与样本
- 系统综述与荟萃分析,纳入192项研究,检测多种遗传和环境ASD动物模型中的mTOR信号。
主要发现
- 随机效应模型识别出mTOR通路相关蛋白的显著改变。
- p-AKT、PTEN、p-mTOR、p-EIF4e、LC3-II、p-S6K和p-S6的亚组分析显示物种、性别、年龄或脑区特异性效应。
- Beclin-1在所有亚组中一致下调。
临床怎么用
- Beclin-1和自噬通路可作为ASD生物标志物与治疗开发的新方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Autism Spectrum Disorder (ASD) is a heterogeneous neurodevelopmental condition with complex etiology, involving genetic and environmental influences on brain development and behavior. Dysregulation of mammalian target of rapamycin (mTOR) signaling alters neuronal growth and synaptic plasticity, and has emerged as a potential underlying pathway in ASD. GOAL AND METHODS: To investigate mTOR dysregulation as a common mechanism in ASD, we performed a systematic review, and a meta-analysis of 192 studies examining mTOR signaling in diverse genetic and environmental animal models. RESULTS: Our random-effects model identified significant alterations in mTOR pathway-related proteins. For several proteins (p-AKT, PTEN, p-mTOR, p-EIF4e, LC3-II, p-S6K and p-S6), subgroup analyses revealed clear species-, sex-, age-, or brain region-specific effects. Interestingly, Beclin-1 was consistently downregulated across all subgroups. CONCLUSION: Our findings support mTOR-pathway dysregulation in ASD. The observed consistent downregulation of Beclin-1 highlights autophagy as a common mechanism, and provides new leads for novel ASD biomarker and treatment development.
引用
- Abromeit A, Hooijmans CR, LeMaoult C, et al. Animal studies reveal downregulation of the Beclin-1 autophagy pathway as shared mechanism in Autism Spectrum Disorder: a systematic review and meta-analysis. Mol Psychiatry. 2025. PMID: 40247126. doi:10.1038/s41380-025-03028-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。